Pescucci Chiara, Mari Francesca, Longo Ilaria, Vogiatzi Paraskevi, Caselli Rossella, Scala Elisa, Abaterusso Cataldo, Gusmano Rosanna, Seri Marco, Miglietti Nunzia, Bresin Elena, Renieri Alessandra
Medical Genetics, Department of Molecular Biology, University of Siena, Siena, Italy.
Kidney Int. 2004 May;65(5):1598-603. doi: 10.1111/j.1523-1755.2004.00560.x.
Alport syndrome is a clinically and genetically heterogeneous nephropathy. The majority of cases are transmitted as an X-linked semidominant condition due to COL4A5 mutations. In this form males are more severely affected than females. Less than 10% of cases are autosomal recessive due to mutation in either COL4A3 or COL4A4. In this rarer form, both males and females are severely affected. Only two cases of autosomal-dominant Alport syndrome have been reported, one due to a COL4A3 mutation and the other due to a COL4A4 mutation. Because of the paucity of the reported families, the natural history of autosomal-dominant Alport syndrome is mostly unknown.
Four families with likely autosomal-dominant Alport syndrome were investigated. COL4A3 and COL4A4 genes were analyzed by denaturing high-performance liquid chromatography (HPLC). Automated sequencing was performed to identify the underlying mutation.
Two families had a mutation in the COL4A4 gene and two in the COL4A3. Accurate clinical evaluation of family members showed interesting results. Affected individuals (22 persons) had a wide range of phenotypes from end-stage renal disease (ESRD) in the fifth decade to a nonprogressive isolated microhematuria. Finally, three heterozygous individuals (90, 22 and 11 years old, respectively) were completely asymptomatic.
This paper demonstrated that patients affected by autosomal-dominant Alport syndrome have a high clinical variability. Moreover, a reduced penetrance of about 90% (3 of 25) may be considered for the assessment of recurrence risk during genetic counseling of these families.
Alport综合征是一种临床和遗传异质性肾病。大多数病例由于COL4A5基因突变以X连锁半显性方式遗传。在这种形式中,男性比女性受影响更严重。不到10%的病例是由于COL4A3或COL4A4基因突变导致的常染色体隐性遗传。在这种较罕见的形式中,男性和女性都受到严重影响。仅报告了两例常染色体显性Alport综合征病例,一例由于COL4A3突变,另一例由于COL4A4突变。由于报告的家族数量稀少,常染色体显性Alport综合征的自然病史大多未知。
对四个可能患有常染色体显性Alport综合征的家族进行了研究。通过变性高效液相色谱法(HPLC)分析COL4A3和COL4A4基因。进行自动测序以识别潜在突变。
两个家族的COL4A4基因发生突变,两个家族的COL4A3基因发生突变。对家族成员进行的准确临床评估显示出有趣的结果。受影响个体(22人)具有广泛的表型,从50多岁的终末期肾病(ESRD)到非进行性孤立性镜下血尿。最后,三名杂合子个体(分别为90岁、22岁和11岁)完全无症状。
本文证明,常染色体显性Alport综合征患者具有高度的临床变异性。此外,在对这些家族进行遗传咨询时评估复发风险时,可考虑约90%(25例中的3例)的低外显率。